Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ultragenyx Pharmaceu
(NQ:
RARE
)
40.90
-0.32 (-0.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ultragenyx Pharmaceu
< Previous
1
2
3
4
Next >
Apple To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Tuesday
June 06, 2023
B of A Securities boosted the price target for Molson Coors Beverage Company (NYSE: TAP) from $54 to $68. B of A Securities analyst Bryan Spillane upgraded the stock from Underperform to Neutral....
Via
Benzinga
Why Ultragenyx Pharma Stock Is Trading Higher Premarket Today
June 06, 2023
Via
Benzinga
Ultragenyx Pharm Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
May 15, 2023
Ultragenyx Pharm shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.
Via
Investor's Business Daily
Ultragenyx Pharmaceutical's Return On Capital Employed Insights
May 15, 2023
Via
Benzinga
Ultragenyx Pharmaceutical: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
A Preview Of Ultragenyx Pharmaceutical's Earnings
May 03, 2023
Via
Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
April 26, 2023
Via
Benzinga
Where Ultragenyx Pharmaceutical Stands With Analysts
February 17, 2023
Via
Benzinga
Earnings Scheduled For February 16, 2023
February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...
Via
Benzinga
Earnings Preview: Ultragenyx Pharmaceutical
February 15, 2023
Via
Benzinga
Analyst Expectations for Ultragenyx Pharmaceutical's Future
January 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
April 26, 2023
Via
Benzinga
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
March 29, 2023
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine.
Via
InvestorPlace
What You Missed On Wall Street On Friday
December 31, 2022
In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold.
Via
Talk Markets
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
December 30, 2022
Via
Benzinga
Analyst Expectations for Ultragenyx Pharmaceutical's Future
December 30, 2022
Via
Benzinga
Where Ultragenyx Pharmaceutical Stands With Analysts
November 03, 2022
Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter:
Via
Benzinga
Analyst Ratings for Ultragenyx Pharmaceutical
July 29, 2022
Within the last quarter, Ultragenyx Pharmaceutical (NASDAQ:RARE) has observed the following analyst ratings:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
November 09, 2022
On Wednesday, 283 companies set new 52-week lows.
Via
Benzinga
Ultragenyx Pharma Posts Smaller Than Expected Q2 Loss, Reaffirms Guidance
July 29, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
November 03, 2022
Upgrades
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
November 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket
August 18, 2022
Gainers
Via
Benzinga
Earnings Scheduled For November 2, 2022
November 02, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 14, 2022
During Wednesday's session, 265 companies made new 52-week lows.
Via
Benzinga
Cisco, Keysight Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 18, 2022
Wolfspeed, Inc. (NYSE: WOLF) rose 20.7% to $103.40 in pre-market trading after the company reported better-than-expected Q4 results.
Via
Benzinga
NVIDIA, Tyson Foods, BioNTech And Some Other Big Stocks Moving Lower On Monday
August 08, 2022
AMTD Digital Inc. (NYSE: HKD) dipped 21.8% to $563.71 on possible profit taking after the stock surged over the last few trading days.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
August 01, 2022
Upgrades
Via
Benzinga
What 7 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical
July 29, 2022
Within the last quarter, Ultragenyx Pharmaceutical (NASDAQ:RARE) has observed the following analyst ratings:
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.